Recombinant Mouse Akr1c13 protein, His&Myc-tagged

• Cat.No.: Akr1c13-1344M
• Product Overview: Recombinant Mouse Akr1c13 protein(Q8VC28)(1-323aa), fused to N-terminal His tag and C-terminal Myc tag, was expressed in E. coli.

Specification

• Source: E. coli
• Species: Mouse
• Tag: His&Myc
• Form: If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
• Molecular Mass: 44.5 kDa
• Protein length: 1-323aa
• Purity: Greater than 85% as determined by SDS-PAGE.
• Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.

Reviews

10/06/2019

Its top-notch purity and integrity instill confidence in obtaining precise and reliable data, thereby enabling significant advancements in my research.

09/10/2019

The Akr1c13 protein showcases outstanding quality, ensuring its suitability for addressing my experimental requirements effectively.

07/14/2019

Coupled with the manufacturer's commitment to impeccable technical support, I am equipped with the necessary tools to overcome any hurdles and achieve significant breakthroughs in my scientific pursuits.

06/23/2019

the manufacturer's dedication to excellent technical support assures me that any challenges or obstacles I encounter will be swiftly resolved.

Q&As

Is there any current research on the AKR1C13 protein?

Due to the limited knowledge about the AKR1C13 protein, there is currently minimal research specifically focused on it. However, ongoing studies exploring the broader AKR enzyme family and related proteins may indirectly provide insights into the function and significance of AKR1C13.

Are there any known diseases associated with mutations in the AKR1C13 gene?

As of now, there is limited information available regarding diseases specifically associated with mutations in the AKR1C13 gene. However, mutations in other members of the AKR enzyme family have been linked to various diseases, including cancer and metabolic disorders. More research is needed to determine if mutations in the AKR1C13 gene have any disease implications.

Can AKR1C13 protein be targeted for therapeutic purposes?

Since the function and significance of the AKR1C13 protein are not well understood, it is not currently targeted for therapeutic purposes. However, further research on its role and potential therapeutic applications may provide opportunities for targeting this protein in the future.